nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—ADRA2B—hypertension	0.0841	0.245	CbGaD
Paliperidone—ADRA1A—hypertension	0.0521	0.151	CbGaD
Paliperidone—HTR1B—hypertension	0.0416	0.121	CbGaD
Paliperidone—DRD3—hypertension	0.0404	0.118	CbGaD
Paliperidone—CYP3A5—hypertension	0.0392	0.114	CbGaD
Paliperidone—ADRA2A—hypertension	0.0369	0.107	CbGaD
Paliperidone—DRD2—hypertension	0.028	0.0813	CbGaD
Paliperidone—HTR2A—hypertension	0.0216	0.0628	CbGaD
Paliperidone—HTR1B—Pindolol—hypertension	0.0128	0.0323	CbGbCtD
Paliperidone—ADRA2C—Guanabenz—hypertension	0.0125	0.0315	CbGbCtD
Paliperidone—ADRA2B—Guanabenz—hypertension	0.0118	0.0299	CbGbCtD
Paliperidone—ADRA2B—Guanfacine—hypertension	0.011	0.0278	CbGbCtD
Paliperidone—HTR1B—Penbutolol—hypertension	0.0104	0.0263	CbGbCtD
Paliperidone—ADRA2C—Fenoldopam—hypertension	0.00985	0.0249	CbGbCtD
Paliperidone—DRD1—Fenoldopam—hypertension	0.00985	0.0249	CbGbCtD
Paliperidone—HTR1A—Nebivolol—hypertension	0.0094	0.0238	CbGbCtD
Paliperidone—ADRA2B—Fenoldopam—hypertension	0.00934	0.0236	CbGbCtD
Paliperidone—ADRA2A—Methyldopa—hypertension	0.00899	0.0227	CbGbCtD
Paliperidone—ADRA1B—Terazosin—hypertension	0.00873	0.0221	CbGbCtD
Paliperidone—HTR1D—Prazosin—hypertension	0.00858	0.0217	CbGbCtD
Paliperidone—ADRA2A—Guanabenz—hypertension	0.00822	0.0208	CbGbCtD
Paliperidone—HTR1A—Pindolol—hypertension	0.00799	0.0202	CbGbCtD
Paliperidone—ADRA1B—Fenoldopam—hypertension	0.0079	0.02	CbGbCtD
Paliperidone—ADRA2A—Guanfacine—hypertension	0.00764	0.0193	CbGbCtD
Paliperidone—ADRA1B—Doxazosin—hypertension	0.00729	0.0184	CbGbCtD
Paliperidone—ADRA2B—Prazosin—hypertension	0.00708	0.0179	CbGbCtD
Paliperidone—ADRA1A—Terazosin—hypertension	0.00689	0.0174	CbGbCtD
Paliperidone—HTR1B—Propranolol—hypertension	0.00653	0.0165	CbGbCtD
Paliperidone—HTR1A—Penbutolol—hypertension	0.00651	0.0165	CbGbCtD
Paliperidone—ADRA2A—Fenoldopam—hypertension	0.0065	0.0164	CbGbCtD
Paliperidone—ADRA2C—Carvedilol—hypertension	0.00644	0.0163	CbGbCtD
Paliperidone—ADRA1A—Fenoldopam—hypertension	0.00623	0.0158	CbGbCtD
Paliperidone—ADRA2B—Carvedilol—hypertension	0.00611	0.0155	CbGbCtD
Paliperidone—ADRA2A—Doxazosin—hypertension	0.006	0.0152	CbGbCtD
Paliperidone—DRD2—Fenoldopam—hypertension	0.00599	0.0151	CbGbCtD
Paliperidone—ADRA1B—Prazosin—hypertension	0.00598	0.0151	CbGbCtD
Paliperidone—ADRA1A—Doxazosin—hypertension	0.00575	0.0146	CbGbCtD
Paliperidone—ADRA2C—Clonidine—hypertension	0.00566	0.0143	CbGbCtD
Paliperidone—ADRA2B—Clonidine—hypertension	0.00537	0.0136	CbGbCtD
Paliperidone—ADRA1B—Nicardipine—hypertension	0.00517	0.0131	CbGbCtD
Paliperidone—ADRA1B—Carvedilol—hypertension	0.00517	0.0131	CbGbCtD
Paliperidone—HTR1A—Prazosin—hypertension	0.00515	0.013	CbGbCtD
Paliperidone—ADRA1B—vas deferens—hypertension	0.005	0.181	CbGeAlD
Paliperidone—ADRA2A—Prazosin—hypertension	0.00493	0.0125	CbGbCtD
Paliperidone—ADRA1A—Prazosin—hypertension	0.00472	0.012	CbGbCtD
Paliperidone—ADRA1B—Clonidine—hypertension	0.00454	0.0115	CbGbCtD
Paliperidone—ADRA2A—Carvedilol—hypertension	0.00425	0.0108	CbGbCtD
Paliperidone—HTR1A—Propranolol—hypertension	0.00409	0.0104	CbGbCtD
Paliperidone—ADRA1A—Nicardipine—hypertension	0.00408	0.0103	CbGbCtD
Paliperidone—ADRA1A—Carvedilol—hypertension	0.00408	0.0103	CbGbCtD
Paliperidone—ADRA2A—Clonidine—hypertension	0.00373	0.00945	CbGbCtD
Paliperidone—CYP3A5—Reserpine—hypertension	0.00369	0.00935	CbGbCtD
Paliperidone—ADRA1A—Clonidine—hypertension	0.00358	0.00906	CbGbCtD
Paliperidone—CYP3A5—Nisoldipine—hypertension	0.00325	0.00823	CbGbCtD
Paliperidone—CYP3A5—Diltiazem—hypertension	0.00314	0.00795	CbGbCtD
Paliperidone—CYP3A5—Eplerenone—hypertension	0.00314	0.00795	CbGbCtD
Paliperidone—CYP2D6—Labetalol—hypertension	0.00299	0.00757	CbGbCtD
Paliperidone—CYP2D6—Nebivolol—hypertension	0.00299	0.00757	CbGbCtD
Paliperidone—CYP2D6—Acebutolol—hypertension	0.00273	0.00692	CbGbCtD
Paliperidone—CYP2D6—Pindolol—hypertension	0.00254	0.00643	CbGbCtD
Paliperidone—CYP2D6—Metoprolol—hypertension	0.00254	0.00643	CbGbCtD
Paliperidone—CYP3A5—Amlodipine—hypertension	0.00251	0.00636	CbGbCtD
Paliperidone—CYP3A4—Guanethidine—hypertension	0.00251	0.00635	CbGbCtD
Paliperidone—CYP3A5—Felodipine—hypertension	0.00242	0.00613	CbGbCtD
Paliperidone—CYP3A5—Nifedipine—hypertension	0.00234	0.00593	CbGbCtD
Paliperidone—CYP3A5—Nicardipine—hypertension	0.00231	0.00584	CbGbCtD
Paliperidone—CYP2D6—Betaxolol—hypertension	0.00227	0.00573	CbGbCtD
Paliperidone—CYP3A5—Propranolol—hypertension	0.00212	0.00537	CbGbCtD
Paliperidone—CYP3A5—Clonidine—hypertension	0.00202	0.00512	CbGbCtD
Paliperidone—CYP2D6—Doxazosin—hypertension	0.00199	0.00505	CbGbCtD
Paliperidone—CYP2D6—Diltiazem—hypertension	0.00193	0.00488	CbGbCtD
Paliperidone—CYP3A4—Hydralazine—hypertension	0.0019	0.00481	CbGbCtD
Paliperidone—CYP3A5—Atorvastatin—hypertension	0.0018	0.00457	CbGbCtD
Paliperidone—CYP2D6—Bepridil—hypertension	0.00172	0.00435	CbGbCtD
Paliperidone—CYP3A5—Losartan—hypertension	0.00165	0.00418	CbGbCtD
Paliperidone—CYP3A4—Guanfacine—hypertension	0.00162	0.00409	CbGbCtD
Paliperidone—CYP2D6—Irbesartan—hypertension	0.00157	0.00397	CbGbCtD
Paliperidone—CYP2D6—Amlodipine—hypertension	0.00154	0.0039	CbGbCtD
Paliperidone—CYP2D6—Felodipine—hypertension	0.00149	0.00376	CbGbCtD
Paliperidone—CYP2D6—Timolol—hypertension	0.00146	0.00369	CbGbCtD
Paliperidone—CYP3A5—Verapamil—hypertension	0.00146	0.00369	CbGbCtD
Paliperidone—CYP3A4—Isradipine—hypertension	0.00144	0.00365	CbGbCtD
Paliperidone—CYP2D6—Nifedipine—hypertension	0.00144	0.00363	CbGbCtD
Paliperidone—CYP2D6—Carvedilol—hypertension	0.00141	0.00358	CbGbCtD
Paliperidone—CYP2D6—Nicardipine—hypertension	0.00141	0.00358	CbGbCtD
Paliperidone—CYP2D6—Propranolol—hypertension	0.0013	0.00329	CbGbCtD
Paliperidone—HTR2A—arteriole—hypertension	0.00129	0.0468	CbGeAlD
Paliperidone—CYP2D6—Captopril—hypertension	0.00129	0.00325	CbGbCtD
Paliperidone—CYP3A4—Nisoldipine—hypertension	0.00127	0.00321	CbGbCtD
Paliperidone—CYP3A4—Indapamide—hypertension	0.00127	0.00321	CbGbCtD
Paliperidone—CYP2D6—Clonidine—hypertension	0.00124	0.00314	CbGbCtD
Paliperidone—CYP3A4—Diltiazem—hypertension	0.00122	0.0031	CbGbCtD
Paliperidone—CYP3A4—Eplerenone—hypertension	0.00122	0.0031	CbGbCtD
Paliperidone—CYP2D6—Atorvastatin—hypertension	0.00111	0.0028	CbGbCtD
Paliperidone—CYP3A4—Enalapril—hypertension	0.00109	0.00276	CbGbCtD
Paliperidone—HTR2A—locus ceruleus—hypertension	0.00104	0.0377	CbGeAlD
Paliperidone—CYP3A4—Irbesartan—hypertension	0.000999	0.00253	CbGbCtD
Paliperidone—CYP3A4—Amlodipine—hypertension	0.000979	0.00248	CbGbCtD
Paliperidone—CYP3A4—Felodipine—hypertension	0.000944	0.00239	CbGbCtD
Paliperidone—CYP3A4—Nifedipine—hypertension	0.000913	0.00231	CbGbCtD
Paliperidone—CYP3A4—Nicardipine—hypertension	0.000899	0.00228	CbGbCtD
Paliperidone—CYP3A4—Carvedilol—hypertension	0.000899	0.00228	CbGbCtD
Paliperidone—CYP2D6—Verapamil—hypertension	0.000893	0.00226	CbGbCtD
Paliperidone—HTR2A—pulmonary artery—hypertension	0.000848	0.0307	CbGeAlD
Paliperidone—CYP3A4—Propranolol—hypertension	0.000827	0.00209	CbGbCtD
Paliperidone—HTR2A—sympathetic nervous system—hypertension	0.000825	0.0298	CbGeAlD
Paliperidone—HTR2A—vagus nerve—hypertension	0.000799	0.0289	CbGeAlD
Paliperidone—CYP3A4—Clonidine—hypertension	0.000789	0.002	CbGbCtD
Paliperidone—HTR2A—vein—hypertension	0.000772	0.0279	CbGeAlD
Paliperidone—CYP3A4—Atorvastatin—hypertension	0.000704	0.00178	CbGbCtD
Paliperidone—HTR1B—artery—hypertension	0.000654	0.0236	CbGeAlD
Paliperidone—CYP3A4—Losartan—hypertension	0.000643	0.00163	CbGbCtD
Paliperidone—HTR1D—artery—hypertension	0.000633	0.0229	CbGeAlD
Paliperidone—DRD4—heart—hypertension	0.00059	0.0213	CbGeAlD
Paliperidone—CYP3A4—Verapamil—hypertension	0.000568	0.00144	CbGbCtD
Paliperidone—HTR2A—autonomic nervous system—hypertension	0.000555	0.02	CbGeAlD
Paliperidone—HTR2A—hindlimb—hypertension	0.000513	0.0185	CbGeAlD
Paliperidone—HTR1B—blood vessel—hypertension	0.000509	0.0184	CbGeAlD
Paliperidone—HTR1D—blood vessel—hypertension	0.000493	0.0178	CbGeAlD
Paliperidone—HTR2A—urine—hypertension	0.000452	0.0163	CbGeAlD
Paliperidone—CYP3A4—urine—hypertension	0.000418	0.0151	CbGeAlD
Paliperidone—CYP2D6—urine—hypertension	0.000412	0.0149	CbGeAlD
Paliperidone—Risperidone—ADRA2B—hypertension	0.000364	0.12	CrCbGaD
Paliperidone—DRD1—brainstem—hypertension	0.000344	0.0124	CbGeAlD
Paliperidone—HTR2A—artery—hypertension	0.000314	0.0114	CbGeAlD
Paliperidone—Risperidone—HTR2B—hypertension	0.0003	0.099	CrCbGaD
Paliperidone—ADRA1B—kidney—hypertension	0.000294	0.0106	CbGeAlD
Paliperidone—HTR1B—brainstem—hypertension	0.000278	0.0101	CbGeAlD
Paliperidone—HTR1D—brainstem—hypertension	0.00027	0.00974	CbGeAlD
Paliperidone—HTR2C—brainstem—hypertension	0.000267	0.00965	CbGeAlD
Paliperidone—HTR2A—endothelium—hypertension	0.000266	0.0096	CbGeAlD
Paliperidone—ADRA2C—cardiac ventricle—hypertension	0.00026	0.0094	CbGeAlD
Paliperidone—HTR2A—blood vessel—hypertension	0.000245	0.00885	CbGeAlD
Paliperidone—ADRA2C—myocardium—hypertension	0.000245	0.00884	CbGeAlD
Paliperidone—DRD3—central nervous system—hypertension	0.000242	0.00875	CbGeAlD
Paliperidone—HTR1B—cardiovascular system—hypertension	0.000227	0.00821	CbGeAlD
Paliperidone—Risperidone—ADRA1A—hypertension	0.000225	0.0743	CrCbGaD
Paliperidone—HTR1A—brainstem—hypertension	0.000225	0.00812	CbGeAlD
Paliperidone—HTR1D—cardiovascular system—hypertension	0.00022	0.00795	CbGeAlD
Paliperidone—HTR1D—kidney—hypertension	0.000215	0.00778	CbGeAlD
Paliperidone—Iloperidone—ADRA1A—hypertension	0.000211	0.0697	CrCbGaD
Paliperidone—ADRA1A—brainstem—hypertension	0.000207	0.00749	CbGeAlD
Paliperidone—DRD2—brainstem—hypertension	0.000203	0.00734	CbGeAlD
Paliperidone—HTR2C—medulla oblongata—hypertension	0.000186	0.00673	CbGeAlD
Paliperidone—ADRA1B—central nervous system—hypertension	0.000186	0.00672	CbGeAlD
Paliperidone—Risperidone—HTR7—hypertension	0.000186	0.0613	CrCbGaD
Paliperidone—HTR1A—cardiovascular system—hypertension	0.000183	0.00663	CbGeAlD
Paliperidone—Risperidone—HTR1B—hypertension	0.00018	0.0594	CrCbGaD
Paliperidone—ADRA2C—nephron tubule—hypertension	0.000179	0.00648	CbGeAlD
Paliperidone—ADRA1A—heart—hypertension	0.000179	0.00647	CbGeAlD
Paliperidone—ADRA2C—adrenal cortex—hypertension	0.000176	0.00638	CbGeAlD
Paliperidone—Risperidone—DRD3—hypertension	0.000175	0.0576	CrCbGaD
Paliperidone—Iloperidone—HTR7—hypertension	0.000174	0.0575	CrCbGaD
Paliperidone—DRD1—central nervous system—hypertension	0.000173	0.00626	CbGeAlD
Paliperidone—ADRA2C—heart—hypertension	0.000171	0.00617	CbGeAlD
Paliperidone—Risperidone—CYP3A5—hypertension	0.000169	0.0558	CrCbGaD
Paliperidone—ADRA1A—cardiovascular system—hypertension	0.000169	0.00611	CbGeAlD
Paliperidone—ADRA2C—decidua—hypertension	0.000166	0.006	CbGeAlD
Paliperidone—Iloperidone—DRD3—hypertension	0.000164	0.0541	CrCbGaD
Paliperidone—Risperidone—ADRA2A—hypertension	0.000159	0.0526	CrCbGaD
Paliperidone—Iloperidone—CYP3A5—hypertension	0.000159	0.0524	CrCbGaD
Paliperidone—ADRA2C—kidney—hypertension	0.000158	0.0057	CbGeAlD
Paliperidone—HTR1B—endocrine gland—hypertension	0.000156	0.00563	CbGeAlD
Paliperidone—ADRA2C—cortex of kidney—hypertension	0.000153	0.00555	CbGeAlD
Paliperidone—CYP3A5—nephron tubule—hypertension	0.00015	0.00542	CbGeAlD
Paliperidone—Iloperidone—ADRA2A—hypertension	0.00015	0.0493	CrCbGaD
Paliperidone—ADRA2C—cardiac atrium—hypertension	0.000146	0.00528	CbGeAlD
Paliperidone—HTR1A—adrenal gland—hypertension	0.000145	0.00524	CbGeAlD
Paliperidone—HTR1B—central nervous system—hypertension	0.00014	0.00508	CbGeAlD
Paliperidone—ADRA2C—medulla oblongata—hypertension	0.000138	0.00497	CbGeAlD
Paliperidone—HRH1—smooth muscle tissue—hypertension	0.000138	0.00497	CbGeAlD
Paliperidone—ADRA2A—heart—hypertension	0.000136	0.00492	CbGeAlD
Paliperidone—HTR1D—central nervous system—hypertension	0.000136	0.00491	CbGeAlD
Paliperidone—HRH1—decidua—hypertension	0.000135	0.00487	CbGeAlD
Paliperidone—HTR2C—central nervous system—hypertension	0.000135	0.00487	CbGeAlD
Paliperidone—HTR2A—brainstem—hypertension	0.000134	0.00484	CbGeAlD
Paliperidone—ADRA1A—adrenal gland—hypertension	0.000134	0.00483	CbGeAlD
Paliperidone—ADRA2A—decidua—hypertension	0.000132	0.00479	CbGeAlD
Paliperidone—CYP3A5—kidney—hypertension	0.000132	0.00477	CbGeAlD
Paliperidone—CYP3A5—cortex of kidney—hypertension	0.000128	0.00464	CbGeAlD
Paliperidone—ADRA2C—adrenal gland—hypertension	0.000127	0.0046	CbGeAlD
Paliperidone—HTR1A—endocrine gland—hypertension	0.000126	0.00455	CbGeAlD
Paliperidone—ADRA2A—cortex of kidney—hypertension	0.000122	0.00443	CbGeAlD
Paliperidone—CYP2D6—brainstem—hypertension	0.000122	0.00441	CbGeAlD
Paliperidone—Risperidone—DRD2—hypertension	0.000121	0.0399	CrCbGaD
Paliperidone—ADRA2A—cardiac atrium—hypertension	0.000116	0.00421	CbGeAlD
Paliperidone—ADRA1A—endocrine gland—hypertension	0.000116	0.00419	CbGeAlD
Paliperidone—HTR2A—heart—hypertension	0.000116	0.00419	CbGeAlD
Paliperidone—HTR2A—smooth muscle tissue—hypertension	0.000115	0.00415	CbGeAlD
Paliperidone—DRD2—endocrine gland—hypertension	0.000114	0.00411	CbGeAlD
Paliperidone—Iloperidone—DRD2—hypertension	0.000113	0.0374	CrCbGaD
Paliperidone—HTR1A—central nervous system—hypertension	0.000113	0.0041	CbGeAlD
Paliperidone—ADRA2A—medulla oblongata—hypertension	0.00011	0.00397	CbGeAlD
Paliperidone—HTR2A—cardiovascular system—hypertension	0.000109	0.00395	CbGeAlD
Paliperidone—HTR2A—kidney—hypertension	0.000107	0.00386	CbGeAlD
Paliperidone—ADRA1A—central nervous system—hypertension	0.000104	0.00378	CbGeAlD
Paliperidone—HRH1—adrenal gland—hypertension	0.000103	0.00374	CbGeAlD
Paliperidone—DRD2—central nervous system—hypertension	0.000102	0.0037	CbGeAlD
Paliperidone—ADRA2A—adrenal gland—hypertension	0.000102	0.00367	CbGeAlD
Paliperidone—ADRA2C—central nervous system—hypertension	9.96e-05	0.0036	CbGeAlD
Paliperidone—CYP3A4—kidney—hypertension	9.9e-05	0.00358	CbGeAlD
Paliperidone—CYP2D6—kidney—hypertension	9.74e-05	0.00352	CbGeAlD
Paliperidone—Risperidone—HTR2A—hypertension	9.35e-05	0.0308	CrCbGaD
Paliperidone—HTR2A—medulla oblongata—hypertension	9.34e-05	0.00337	CbGeAlD
Paliperidone—CYP3A5—endocrine gland—hypertension	9.25e-05	0.00334	CbGeAlD
Paliperidone—HRH1—endocrine gland—hypertension	8.97e-05	0.00324	CbGeAlD
Paliperidone—ADRA2A—endocrine gland—hypertension	8.82e-05	0.00319	CbGeAlD
Paliperidone—Iloperidone—HTR2A—hypertension	8.77e-05	0.0289	CrCbGaD
Paliperidone—HTR2A—adrenal gland—hypertension	8.64e-05	0.00312	CbGeAlD
Paliperidone—HRH1—central nervous system—hypertension	8.09e-05	0.00292	CbGeAlD
Paliperidone—ADRA2A—central nervous system—hypertension	7.94e-05	0.00287	CbGeAlD
Paliperidone—HTR2A—endocrine gland—hypertension	7.5e-05	0.00271	CbGeAlD
Paliperidone—CYP3A4—endocrine gland—hypertension	6.94e-05	0.00251	CbGeAlD
Paliperidone—CYP2D6—endocrine gland—hypertension	6.83e-05	0.00247	CbGeAlD
Paliperidone—HTR2A—central nervous system—hypertension	6.75e-05	0.00244	CbGeAlD
Paliperidone—CYP3A4—central nervous system—hypertension	6.25e-05	0.00226	CbGeAlD
Paliperidone—CYP2D6—central nervous system—hypertension	6.15e-05	0.00222	CbGeAlD
Paliperidone—Body temperature increased—Irbesartan—hypertension	1.02e-05	7.25e-05	CcSEcCtD
Paliperidone—Thrombocytopenia—Ramipril—hypertension	1.02e-05	7.25e-05	CcSEcCtD
Paliperidone—Oedema—Timolol—hypertension	1.02e-05	7.24e-05	CcSEcCtD
Paliperidone—Anaphylactic shock—Timolol—hypertension	1.02e-05	7.24e-05	CcSEcCtD
Paliperidone—Loss of consciousness—Lisinopril—hypertension	1.02e-05	7.23e-05	CcSEcCtD
Paliperidone—Rash—Verapamil—hypertension	1.02e-05	7.23e-05	CcSEcCtD
Paliperidone—Urticaria—Hydrochlorothiazide—hypertension	1.02e-05	7.23e-05	CcSEcCtD
Paliperidone—Tachycardia—Ramipril—hypertension	1.02e-05	7.23e-05	CcSEcCtD
Paliperidone—Dermatitis—Verapamil—hypertension	1.02e-05	7.22e-05	CcSEcCtD
Paliperidone—Headache—Nifedipine—hypertension	1.02e-05	7.22e-05	CcSEcCtD
Paliperidone—Pruritus—Clonidine—hypertension	1.02e-05	7.2e-05	CcSEcCtD
Paliperidone—Abdominal pain—Hydrochlorothiazide—hypertension	1.02e-05	7.19e-05	CcSEcCtD
Paliperidone—Body temperature increased—Hydrochlorothiazide—hypertension	1.02e-05	7.19e-05	CcSEcCtD
Paliperidone—Skin disorder—Ramipril—hypertension	1.02e-05	7.19e-05	CcSEcCtD
Paliperidone—Infection—Timolol—hypertension	1.02e-05	7.19e-05	CcSEcCtD
Paliperidone—Headache—Verapamil—hypertension	1.02e-05	7.18e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Telmisartan—hypertension	1.02e-05	7.18e-05	CcSEcCtD
Paliperidone—Cough—Lisinopril—hypertension	1.01e-05	7.18e-05	CcSEcCtD
Paliperidone—Nausea—Diltiazem—hypertension	1.01e-05	7.17e-05	CcSEcCtD
Paliperidone—Nausea—Indapamide—hypertension	1.01e-05	7.17e-05	CcSEcCtD
Paliperidone—Asthenia—Trandolapril—hypertension	1.01e-05	7.12e-05	CcSEcCtD
Paliperidone—Shock—Timolol—hypertension	1.01e-05	7.12e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Losartan—hypertension	1.01e-05	7.12e-05	CcSEcCtD
Paliperidone—Urticaria—Furosemide—hypertension	1e-05	7.11e-05	CcSEcCtD
Paliperidone—Nervous system disorder—Timolol—hypertension	1e-05	7.1e-05	CcSEcCtD
Paliperidone—Nausea—Carvedilol—hypertension	1e-05	7.1e-05	CcSEcCtD
Paliperidone—Asthenia—Enalapril—hypertension	1e-05	7.09e-05	CcSEcCtD
Paliperidone—Abdominal pain—Furosemide—hypertension	1e-05	7.08e-05	CcSEcCtD
Paliperidone—Body temperature increased—Furosemide—hypertension	1e-05	7.08e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Losartan—hypertension	9.98e-06	7.06e-05	CcSEcCtD
Paliperidone—Dizziness—Valsartan—hypertension	9.98e-06	7.06e-05	CcSEcCtD
Paliperidone—Anorexia—Ramipril—hypertension	9.97e-06	7.06e-05	CcSEcCtD
Paliperidone—Urticaria—Betaxolol—hypertension	9.94e-06	7.04e-05	CcSEcCtD
Paliperidone—Skin disorder—Timolol—hypertension	9.93e-06	7.03e-05	CcSEcCtD
Paliperidone—Dizziness—Olmesartan—hypertension	9.93e-06	7.03e-05	CcSEcCtD
Paliperidone—Pruritus—Trandolapril—hypertension	9.92e-06	7.02e-05	CcSEcCtD
Paliperidone—Nausea—Doxazosin—hypertension	9.92e-06	7.02e-05	CcSEcCtD
Paliperidone—Chest pain—Lisinopril—hypertension	9.9e-06	7.01e-05	CcSEcCtD
Paliperidone—Arthralgia—Lisinopril—hypertension	9.9e-06	7.01e-05	CcSEcCtD
Paliperidone—Myalgia—Lisinopril—hypertension	9.9e-06	7.01e-05	CcSEcCtD
Paliperidone—Body temperature increased—Betaxolol—hypertension	9.9e-06	7e-05	CcSEcCtD
Paliperidone—Asthenia—Telmisartan—hypertension	9.88e-06	7e-05	CcSEcCtD
Paliperidone—Pruritus—Enalapril—hypertension	9.88e-06	6.99e-05	CcSEcCtD
Paliperidone—Anxiety—Lisinopril—hypertension	9.86e-06	6.98e-05	CcSEcCtD
Paliperidone—Diarrhoea—Clonidine—hypertension	9.84e-06	6.96e-05	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	9.83e-06	6.96e-05	CcSEcCtD
Paliperidone—Nausea—Fosinopril—hypertension	9.8e-06	6.93e-05	CcSEcCtD
Paliperidone—Discomfort—Lisinopril—hypertension	9.78e-06	6.92e-05	CcSEcCtD
Paliperidone—Hypotension—Ramipril—hypertension	9.78e-06	6.92e-05	CcSEcCtD
Paliperidone—Anorexia—Timolol—hypertension	9.75e-06	6.9e-05	CcSEcCtD
Paliperidone—Pruritus—Telmisartan—hypertension	9.75e-06	6.9e-05	CcSEcCtD
Paliperidone—Nausea—Eplerenone—hypertension	9.74e-06	6.89e-05	CcSEcCtD
Paliperidone—Urticaria—Losartan—hypertension	9.69e-06	6.86e-05	CcSEcCtD
Paliperidone—Dry mouth—Lisinopril—hypertension	9.68e-06	6.85e-05	CcSEcCtD
Paliperidone—Nausea—Nifedipine—hypertension	9.67e-06	6.84e-05	CcSEcCtD
Paliperidone—Body temperature increased—Losartan—hypertension	9.64e-06	6.83e-05	CcSEcCtD
Paliperidone—Abdominal pain—Losartan—hypertension	9.64e-06	6.83e-05	CcSEcCtD
Paliperidone—Nausea—Verapamil—hypertension	9.62e-06	6.81e-05	CcSEcCtD
Paliperidone—Asthenia—Captopril—hypertension	9.61e-06	6.8e-05	CcSEcCtD
Paliperidone—Diarrhoea—Trandolapril—hypertension	9.6e-06	6.79e-05	CcSEcCtD
Paliperidone—Vomiting—Valsartan—hypertension	9.59e-06	6.79e-05	CcSEcCtD
Paliperidone—Confusional state—Lisinopril—hypertension	9.57e-06	6.77e-05	CcSEcCtD
Paliperidone—Diarrhoea—Enalapril—hypertension	9.56e-06	6.76e-05	CcSEcCtD
Paliperidone—Hypotension—Timolol—hypertension	9.56e-06	6.76e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Irbesartan—hypertension	9.55e-06	6.76e-05	CcSEcCtD
Paliperidone—Vomiting—Olmesartan—hypertension	9.55e-06	6.76e-05	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Ramipril—hypertension	9.53e-06	6.75e-05	CcSEcCtD
Paliperidone—Rash—Valsartan—hypertension	9.51e-06	6.73e-05	CcSEcCtD
Paliperidone—Dizziness—Clonidine—hypertension	9.51e-06	6.73e-05	CcSEcCtD
Paliperidone—Dermatitis—Valsartan—hypertension	9.5e-06	6.73e-05	CcSEcCtD
Paliperidone—Anaphylactic shock—Lisinopril—hypertension	9.49e-06	6.72e-05	CcSEcCtD
Paliperidone—Oedema—Lisinopril—hypertension	9.49e-06	6.72e-05	CcSEcCtD
Paliperidone—Pruritus—Captopril—hypertension	9.48e-06	6.71e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrochlorothiazide—hypertension	9.47e-06	6.71e-05	CcSEcCtD
Paliperidone—Rash—Olmesartan—hypertension	9.47e-06	6.7e-05	CcSEcCtD
Paliperidone—Insomnia—Ramipril—hypertension	9.46e-06	6.7e-05	CcSEcCtD
Paliperidone—Dermatitis—Olmesartan—hypertension	9.46e-06	6.69e-05	CcSEcCtD
Paliperidone—Headache—Valsartan—hypertension	9.45e-06	6.69e-05	CcSEcCtD
Paliperidone—Diarrhoea—Telmisartan—hypertension	9.43e-06	6.67e-05	CcSEcCtD
Paliperidone—Infection—Lisinopril—hypertension	9.43e-06	6.67e-05	CcSEcCtD
Paliperidone—Headache—Olmesartan—hypertension	9.4e-06	6.66e-05	CcSEcCtD
Paliperidone—Paraesthesia—Ramipril—hypertension	9.39e-06	6.65e-05	CcSEcCtD
Paliperidone—Shock—Lisinopril—hypertension	9.33e-06	6.61e-05	CcSEcCtD
Paliperidone—Asthenia—Perindopril—hypertension	9.33e-06	6.61e-05	CcSEcCtD
Paliperidone—Dyspnoea—Ramipril—hypertension	9.33e-06	6.6e-05	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Timolol—hypertension	9.32e-06	6.6e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Furosemide—hypertension	9.32e-06	6.59e-05	CcSEcCtD
Paliperidone—Asthenia—Irbesartan—hypertension	9.3e-06	6.58e-05	CcSEcCtD
Paliperidone—Somnolence—Ramipril—hypertension	9.3e-06	6.58e-05	CcSEcCtD
Paliperidone—Thrombocytopenia—Lisinopril—hypertension	9.29e-06	6.58e-05	CcSEcCtD
Paliperidone—Dizziness—Trandolapril—hypertension	9.27e-06	6.56e-05	CcSEcCtD
Paliperidone—Tachycardia—Lisinopril—hypertension	9.26e-06	6.55e-05	CcSEcCtD
Paliperidone—Insomnia—Timolol—hypertension	9.25e-06	6.55e-05	CcSEcCtD
Paliperidone—Dizziness—Enalapril—hypertension	9.24e-06	6.54e-05	CcSEcCtD
Paliperidone—Asthenia—Hydrochlorothiazide—hypertension	9.23e-06	6.53e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Betaxolol—hypertension	9.22e-06	6.53e-05	CcSEcCtD
Paliperidone—Skin disorder—Lisinopril—hypertension	9.22e-06	6.52e-05	CcSEcCtD
Paliperidone—Dyspepsia—Ramipril—hypertension	9.21e-06	6.52e-05	CcSEcCtD
Paliperidone—Pruritus—Perindopril—hypertension	9.2e-06	6.51e-05	CcSEcCtD
Paliperidone—Paraesthesia—Timolol—hypertension	9.18e-06	6.5e-05	CcSEcCtD
Paliperidone—Pruritus—Irbesartan—hypertension	9.17e-06	6.49e-05	CcSEcCtD
Paliperidone—Diarrhoea—Captopril—hypertension	9.17e-06	6.49e-05	CcSEcCtD
Paliperidone—Vomiting—Clonidine—hypertension	9.14e-06	6.47e-05	CcSEcCtD
Paliperidone—Dyspnoea—Timolol—hypertension	9.12e-06	6.45e-05	CcSEcCtD
Paliperidone—Dizziness—Telmisartan—hypertension	9.11e-06	6.45e-05	CcSEcCtD
Paliperidone—Pruritus—Hydrochlorothiazide—hypertension	9.1e-06	6.44e-05	CcSEcCtD
Paliperidone—Decreased appetite—Ramipril—hypertension	9.09e-06	6.44e-05	CcSEcCtD
Paliperidone—Somnolence—Timolol—hypertension	9.09e-06	6.44e-05	CcSEcCtD
Paliperidone—Asthenia—Furosemide—hypertension	9.07e-06	6.42e-05	CcSEcCtD
Paliperidone—Rash—Clonidine—hypertension	9.07e-06	6.42e-05	CcSEcCtD
Paliperidone—Dermatitis—Clonidine—hypertension	9.06e-06	6.41e-05	CcSEcCtD
Paliperidone—Anorexia—Lisinopril—hypertension	9.04e-06	6.4e-05	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Ramipril—hypertension	9.03e-06	6.39e-05	CcSEcCtD
Paliperidone—Fatigue—Ramipril—hypertension	9.02e-06	6.38e-05	CcSEcCtD
Paliperidone—Headache—Clonidine—hypertension	9.01e-06	6.38e-05	CcSEcCtD
Paliperidone—Dyspepsia—Timolol—hypertension	9e-06	6.37e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Losartan—hypertension	8.99e-06	6.36e-05	CcSEcCtD
Paliperidone—Asthenia—Betaxolol—hypertension	8.98e-06	6.36e-05	CcSEcCtD
Paliperidone—Nausea—Valsartan—hypertension	8.96e-06	6.34e-05	CcSEcCtD
Paliperidone—Pruritus—Furosemide—hypertension	8.95e-06	6.33e-05	CcSEcCtD
Paliperidone—Constipation—Ramipril—hypertension	8.95e-06	6.33e-05	CcSEcCtD
Paliperidone—Nausea—Olmesartan—hypertension	8.92e-06	6.31e-05	CcSEcCtD
Paliperidone—Vomiting—Trandolapril—hypertension	8.92e-06	6.31e-05	CcSEcCtD
Paliperidone—Diarrhoea—Perindopril—hypertension	8.9e-06	6.3e-05	CcSEcCtD
Paliperidone—Decreased appetite—Timolol—hypertension	8.89e-06	6.29e-05	CcSEcCtD
Paliperidone—Vomiting—Enalapril—hypertension	8.88e-06	6.29e-05	CcSEcCtD
Paliperidone—Diarrhoea—Irbesartan—hypertension	8.87e-06	6.28e-05	CcSEcCtD
Paliperidone—Hypotension—Lisinopril—hypertension	8.87e-06	6.28e-05	CcSEcCtD
Paliperidone—Dizziness—Captopril—hypertension	8.86e-06	6.27e-05	CcSEcCtD
Paliperidone—Pruritus—Betaxolol—hypertension	8.86e-06	6.27e-05	CcSEcCtD
Paliperidone—Rash—Trandolapril—hypertension	8.84e-06	6.26e-05	CcSEcCtD
Paliperidone—Dermatitis—Trandolapril—hypertension	8.83e-06	6.25e-05	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Timolol—hypertension	8.83e-06	6.25e-05	CcSEcCtD
Paliperidone—Fatigue—Timolol—hypertension	8.82e-06	6.24e-05	CcSEcCtD
Paliperidone—Rash—Enalapril—hypertension	8.81e-06	6.23e-05	CcSEcCtD
Paliperidone—Dermatitis—Enalapril—hypertension	8.8e-06	6.23e-05	CcSEcCtD
Paliperidone—Diarrhoea—Hydrochlorothiazide—hypertension	8.8e-06	6.23e-05	CcSEcCtD
Paliperidone—Headache—Trandolapril—hypertension	8.79e-06	6.22e-05	CcSEcCtD
Paliperidone—Vomiting—Telmisartan—hypertension	8.76e-06	6.2e-05	CcSEcCtD
Paliperidone—Asthenia—Losartan—hypertension	8.75e-06	6.2e-05	CcSEcCtD
Paliperidone—Headache—Enalapril—hypertension	8.75e-06	6.19e-05	CcSEcCtD
Paliperidone—Pain—Timolol—hypertension	8.75e-06	6.19e-05	CcSEcCtD
Paliperidone—Rash—Telmisartan—hypertension	8.69e-06	6.15e-05	CcSEcCtD
Paliperidone—Dermatitis—Telmisartan—hypertension	8.68e-06	6.14e-05	CcSEcCtD
Paliperidone—Diarrhoea—Furosemide—hypertension	8.65e-06	6.12e-05	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Lisinopril—hypertension	8.64e-06	6.12e-05	CcSEcCtD
Paliperidone—Pruritus—Losartan—hypertension	8.63e-06	6.11e-05	CcSEcCtD
Paliperidone—Headache—Telmisartan—hypertension	8.63e-06	6.11e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Ramipril—hypertension	8.62e-06	6.1e-05	CcSEcCtD
Paliperidone—Dizziness—Perindopril—hypertension	8.6e-06	6.09e-05	CcSEcCtD
Paliperidone—Insomnia—Lisinopril—hypertension	8.58e-06	6.07e-05	CcSEcCtD
Paliperidone—Dizziness—Irbesartan—hypertension	8.57e-06	6.07e-05	CcSEcCtD
Paliperidone—Diarrhoea—Betaxolol—hypertension	8.57e-06	6.06e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Ramipril—hypertension	8.55e-06	6.06e-05	CcSEcCtD
Paliperidone—Nausea—Clonidine—hypertension	8.54e-06	6.05e-05	CcSEcCtD
Paliperidone—Paraesthesia—Lisinopril—hypertension	8.52e-06	6.03e-05	CcSEcCtD
Paliperidone—Vomiting—Captopril—hypertension	8.52e-06	6.03e-05	CcSEcCtD
Paliperidone—Dizziness—Hydrochlorothiazide—hypertension	8.5e-06	6.02e-05	CcSEcCtD
Paliperidone—Dyspnoea—Lisinopril—hypertension	8.46e-06	5.99e-05	CcSEcCtD
Paliperidone—Rash—Captopril—hypertension	8.45e-06	5.98e-05	CcSEcCtD
Paliperidone—Dermatitis—Captopril—hypertension	8.44e-06	5.97e-05	CcSEcCtD
Paliperidone—Somnolence—Lisinopril—hypertension	8.43e-06	5.97e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Timolol—hypertension	8.43e-06	5.97e-05	CcSEcCtD
Paliperidone—Headache—Captopril—hypertension	8.39e-06	5.94e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Timolol—hypertension	8.36e-06	5.92e-05	CcSEcCtD
Paliperidone—Dizziness—Furosemide—hypertension	8.36e-06	5.92e-05	CcSEcCtD
Paliperidone—Dyspepsia—Lisinopril—hypertension	8.35e-06	5.91e-05	CcSEcCtD
Paliperidone—Diarrhoea—Losartan—hypertension	8.35e-06	5.91e-05	CcSEcCtD
Paliperidone—Nausea—Trandolapril—hypertension	8.33e-06	5.9e-05	CcSEcCtD
Paliperidone—Urticaria—Ramipril—hypertension	8.31e-06	5.88e-05	CcSEcCtD
Paliperidone—Nausea—Enalapril—hypertension	8.3e-06	5.87e-05	CcSEcCtD
Paliperidone—Dizziness—Betaxolol—hypertension	8.28e-06	5.86e-05	CcSEcCtD
Paliperidone—Vomiting—Perindopril—hypertension	8.27e-06	5.85e-05	CcSEcCtD
Paliperidone—Abdominal pain—Ramipril—hypertension	8.27e-06	5.85e-05	CcSEcCtD
Paliperidone—Body temperature increased—Ramipril—hypertension	8.27e-06	5.85e-05	CcSEcCtD
Paliperidone—Decreased appetite—Lisinopril—hypertension	8.25e-06	5.84e-05	CcSEcCtD
Paliperidone—Vomiting—Irbesartan—hypertension	8.24e-06	5.83e-05	CcSEcCtD
Paliperidone—Rash—Perindopril—hypertension	8.2e-06	5.81e-05	CcSEcCtD
Paliperidone—Dermatitis—Perindopril—hypertension	8.19e-06	5.8e-05	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Lisinopril—hypertension	8.19e-06	5.8e-05	CcSEcCtD
Paliperidone—Nausea—Telmisartan—hypertension	8.18e-06	5.79e-05	CcSEcCtD
Paliperidone—Fatigue—Lisinopril—hypertension	8.18e-06	5.79e-05	CcSEcCtD
Paliperidone—Vomiting—Hydrochlorothiazide—hypertension	8.18e-06	5.79e-05	CcSEcCtD
Paliperidone—Rash—Irbesartan—hypertension	8.17e-06	5.79e-05	CcSEcCtD
Paliperidone—Dermatitis—Irbesartan—hypertension	8.17e-06	5.78e-05	CcSEcCtD
Paliperidone—Headache—Perindopril—hypertension	8.15e-06	5.77e-05	CcSEcCtD
Paliperidone—Urticaria—Timolol—hypertension	8.12e-06	5.75e-05	CcSEcCtD
Paliperidone—Headache—Irbesartan—hypertension	8.12e-06	5.75e-05	CcSEcCtD
Paliperidone—Pain—Lisinopril—hypertension	8.11e-06	5.74e-05	CcSEcCtD
Paliperidone—Constipation—Lisinopril—hypertension	8.11e-06	5.74e-05	CcSEcCtD
Paliperidone—Rash—Hydrochlorothiazide—hypertension	8.11e-06	5.74e-05	CcSEcCtD
Paliperidone—Dermatitis—Hydrochlorothiazide—hypertension	8.1e-06	5.73e-05	CcSEcCtD
Paliperidone—Body temperature increased—Timolol—hypertension	8.08e-06	5.72e-05	CcSEcCtD
Paliperidone—Abdominal pain—Timolol—hypertension	8.08e-06	5.72e-05	CcSEcCtD
Paliperidone—Dizziness—Losartan—hypertension	8.07e-06	5.71e-05	CcSEcCtD
Paliperidone—Headache—Hydrochlorothiazide—hypertension	8.05e-06	5.7e-05	CcSEcCtD
Paliperidone—Vomiting—Furosemide—hypertension	8.04e-06	5.69e-05	CcSEcCtD
Paliperidone—Rash—Furosemide—hypertension	7.97e-06	5.64e-05	CcSEcCtD
Paliperidone—Dermatitis—Furosemide—hypertension	7.97e-06	5.64e-05	CcSEcCtD
Paliperidone—Vomiting—Betaxolol—hypertension	7.96e-06	5.63e-05	CcSEcCtD
Paliperidone—Nausea—Captopril—hypertension	7.96e-06	5.63e-05	CcSEcCtD
Paliperidone—Headache—Furosemide—hypertension	7.92e-06	5.61e-05	CcSEcCtD
Paliperidone—Rash—Betaxolol—hypertension	7.89e-06	5.59e-05	CcSEcCtD
Paliperidone—Dermatitis—Betaxolol—hypertension	7.89e-06	5.58e-05	CcSEcCtD
Paliperidone—Headache—Betaxolol—hypertension	7.84e-06	5.55e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Lisinopril—hypertension	7.82e-06	5.53e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Lisinopril—hypertension	7.76e-06	5.49e-05	CcSEcCtD
Paliperidone—Vomiting—Losartan—hypertension	7.76e-06	5.49e-05	CcSEcCtD
Paliperidone—Nausea—Perindopril—hypertension	7.73e-06	5.47e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Ramipril—hypertension	7.71e-06	5.46e-05	CcSEcCtD
Paliperidone—Nausea—Irbesartan—hypertension	7.7e-06	5.45e-05	CcSEcCtD
Paliperidone—Rash—Losartan—hypertension	7.69e-06	5.44e-05	CcSEcCtD
Paliperidone—Dermatitis—Losartan—hypertension	7.69e-06	5.44e-05	CcSEcCtD
Paliperidone—Headache—Losartan—hypertension	7.64e-06	5.41e-05	CcSEcCtD
Paliperidone—Nausea—Hydrochlorothiazide—hypertension	7.64e-06	5.41e-05	CcSEcCtD
Paliperidone—Urticaria—Lisinopril—hypertension	7.54e-06	5.33e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Timolol—hypertension	7.53e-06	5.33e-05	CcSEcCtD
Paliperidone—Nausea—Furosemide—hypertension	7.51e-06	5.32e-05	CcSEcCtD
Paliperidone—Asthenia—Ramipril—hypertension	7.51e-06	5.31e-05	CcSEcCtD
Paliperidone—Abdominal pain—Lisinopril—hypertension	7.5e-06	5.31e-05	CcSEcCtD
Paliperidone—Body temperature increased—Lisinopril—hypertension	7.5e-06	5.31e-05	CcSEcCtD
Paliperidone—Nausea—Betaxolol—hypertension	7.44e-06	5.26e-05	CcSEcCtD
Paliperidone—Pruritus—Ramipril—hypertension	7.4e-06	5.24e-05	CcSEcCtD
Paliperidone—Asthenia—Timolol—hypertension	7.34e-06	5.19e-05	CcSEcCtD
Paliperidone—Nausea—Losartan—hypertension	7.25e-06	5.13e-05	CcSEcCtD
Paliperidone—Pruritus—Timolol—hypertension	7.24e-06	5.12e-05	CcSEcCtD
Paliperidone—Diarrhoea—Ramipril—hypertension	7.16e-06	5.07e-05	CcSEcCtD
Paliperidone—Diarrhoea—Timolol—hypertension	7e-06	4.95e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Lisinopril—hypertension	6.99e-06	4.95e-05	CcSEcCtD
Paliperidone—Dizziness—Ramipril—hypertension	6.92e-06	4.9e-05	CcSEcCtD
Paliperidone—Asthenia—Lisinopril—hypertension	6.81e-06	4.82e-05	CcSEcCtD
Paliperidone—Dizziness—Timolol—hypertension	6.76e-06	4.79e-05	CcSEcCtD
Paliperidone—Pruritus—Lisinopril—hypertension	6.71e-06	4.75e-05	CcSEcCtD
Paliperidone—Vomiting—Ramipril—hypertension	6.65e-06	4.71e-05	CcSEcCtD
Paliperidone—Rash—Ramipril—hypertension	6.6e-06	4.67e-05	CcSEcCtD
Paliperidone—Dermatitis—Ramipril—hypertension	6.59e-06	4.66e-05	CcSEcCtD
Paliperidone—Headache—Ramipril—hypertension	6.55e-06	4.64e-05	CcSEcCtD
Paliperidone—Vomiting—Timolol—hypertension	6.5e-06	4.6e-05	CcSEcCtD
Paliperidone—Diarrhoea—Lisinopril—hypertension	6.49e-06	4.59e-05	CcSEcCtD
Paliperidone—Rash—Timolol—hypertension	6.45e-06	4.56e-05	CcSEcCtD
Paliperidone—Dermatitis—Timolol—hypertension	6.44e-06	4.56e-05	CcSEcCtD
Paliperidone—Headache—Timolol—hypertension	6.41e-06	4.53e-05	CcSEcCtD
Paliperidone—Dizziness—Lisinopril—hypertension	6.27e-06	4.44e-05	CcSEcCtD
Paliperidone—Nausea—Ramipril—hypertension	6.21e-06	4.4e-05	CcSEcCtD
Paliperidone—Nausea—Timolol—hypertension	6.07e-06	4.3e-05	CcSEcCtD
Paliperidone—Vomiting—Lisinopril—hypertension	6.03e-06	4.27e-05	CcSEcCtD
Paliperidone—Rash—Lisinopril—hypertension	5.98e-06	4.23e-05	CcSEcCtD
Paliperidone—Dermatitis—Lisinopril—hypertension	5.98e-06	4.23e-05	CcSEcCtD
Paliperidone—Headache—Lisinopril—hypertension	5.94e-06	4.21e-05	CcSEcCtD
Paliperidone—Nausea—Lisinopril—hypertension	5.64e-06	3.99e-05	CcSEcCtD
Paliperidone—DRD2—Signaling Pathways—RELA—hypertension	5.71e-07	6.41e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PTEN—hypertension	5.71e-07	6.41e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SERPINE1—hypertension	5.69e-07	6.39e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CALM1—hypertension	5.67e-07	6.37e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOE—hypertension	5.65e-07	6.34e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—hypertension	5.64e-07	6.33e-06	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—hypertension	5.64e-07	6.33e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RELA—hypertension	5.62e-07	6.31e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GCG—hypertension	5.61e-07	6.31e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC2A4—hypertension	5.61e-07	6.31e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RELA—hypertension	5.61e-07	6.3e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MTOR—hypertension	5.6e-07	6.29e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CAV1—hypertension	5.6e-07	6.29e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK8—hypertension	5.58e-07	6.27e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOA1—hypertension	5.58e-07	6.27e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—hypertension	5.57e-07	6.25e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—hypertension	5.55e-07	6.23e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—hypertension	5.54e-07	6.23e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CDKN1A—hypertension	5.52e-07	6.2e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—hypertension	5.51e-07	6.19e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PTEN—hypertension	5.51e-07	6.19e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MTOR—hypertension	5.51e-07	6.19e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—FGF2—hypertension	5.51e-07	6.18e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RELA—hypertension	5.5e-07	6.18e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MTOR—hypertension	5.5e-07	6.17e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CDKN1A—hypertension	5.5e-07	6.17e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RHOA—hypertension	5.49e-07	6.16e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PTEN—hypertension	5.48e-07	6.16e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EP300—hypertension	5.44e-07	6.11e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—hypertension	5.44e-07	6.11e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GOT1—hypertension	5.44e-07	6.11e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—hypertension	5.43e-07	6.1e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3R1—hypertension	5.43e-07	6.1e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MTOR—hypertension	5.39e-07	6.06e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK8—hypertension	5.39e-07	6.05e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—hypertension	5.38e-07	6.04e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—hypertension	5.38e-07	6.04e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—hypertension	5.36e-07	6.02e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK8—hypertension	5.36e-07	6.02e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—hypertension	5.35e-07	6.01e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CDKN1A—hypertension	5.34e-07	6e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PTEN—hypertension	5.33e-07	5.99e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MYC—hypertension	5.33e-07	5.98e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—hypertension	5.31e-07	5.97e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—hypertension	5.29e-07	5.95e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SRC—hypertension	5.29e-07	5.95e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—hypertension	5.28e-07	5.93e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—hypertension	5.28e-07	5.93e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—STK11—hypertension	5.28e-07	5.93e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP19A1—hypertension	5.28e-07	5.93e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CDKN1A—hypertension	5.26e-07	5.91e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EP300—hypertension	5.26e-07	5.9e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MYC—hypertension	5.26e-07	5.9e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PTEN—hypertension	5.25e-07	5.89e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—hypertension	5.24e-07	5.89e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EP300—hypertension	5.23e-07	5.87e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK8—hypertension	5.22e-07	5.86e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EGFR—hypertension	5.21e-07	5.85e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—hypertension	5.2e-07	5.84e-06	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—hypertension	5.2e-07	5.84e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—hypertension	5.18e-07	5.82e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTEN—hypertension	5.18e-07	5.82e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—hypertension	5.16e-07	5.79e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EGFR—hypertension	5.14e-07	5.77e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK8—hypertension	5.13e-07	5.77e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—hypertension	5.12e-07	5.75e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—hypertension	5.12e-07	5.75e-06	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—hypertension	5.11e-07	5.74e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RELA—hypertension	5.11e-07	5.74e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SRC—hypertension	5.11e-07	5.74e-06	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—hypertension	5.1e-07	5.73e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EP300—hypertension	5.09e-07	5.71e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SRC—hypertension	5.08e-07	5.71e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—hypertension	5.04e-07	5.66e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—hypertension	5.03e-07	5.65e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—hypertension	5.02e-07	5.64e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MTOR—hypertension	5.01e-07	5.63e-06	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—hypertension	5.01e-07	5.62e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EP300—hypertension	5.01e-07	5.62e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—hypertension	4.98e-07	5.59e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—hypertension	4.95e-07	5.56e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SRC—hypertension	4.95e-07	5.55e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—EP300—hypertension	4.94e-07	5.55e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—hypertension	4.94e-07	5.54e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—hypertension	4.93e-07	5.54e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—hypertension	4.92e-07	5.53e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—COMT—hypertension	4.91e-07	5.51e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SRC—hypertension	4.87e-07	5.47e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—hypertension	4.87e-07	5.47e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—hypertension	4.86e-07	5.46e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—hypertension	4.85e-07	5.45e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CDKN1A—hypertension	4.85e-07	5.45e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNB3—hypertension	4.84e-07	5.43e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARGC1A—hypertension	4.84e-07	5.43e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PTEN—hypertension	4.84e-07	5.43e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—INS—hypertension	4.83e-07	5.42e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMOX1—hypertension	4.82e-07	5.41e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—hypertension	4.82e-07	5.41e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—hypertension	4.82e-07	5.41e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—hypertension	4.79e-07	5.38e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—hypertension	4.78e-07	5.37e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CDKN1A—hypertension	4.77e-07	5.36e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CDKN1A—hypertension	4.76e-07	5.35e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTEN—hypertension	4.76e-07	5.35e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAT—hypertension	4.75e-07	5.34e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTEN—hypertension	4.75e-07	5.34e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTEN—hypertension	4.75e-07	5.33e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MYC—hypertension	4.74e-07	5.33e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—hypertension	4.74e-07	5.32e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK8—hypertension	4.73e-07	5.32e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—hypertension	4.73e-07	5.32e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—hypertension	4.72e-07	5.3e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNAS—hypertension	4.71e-07	5.29e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—hypertension	4.69e-07	5.27e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CDKN1A—hypertension	4.67e-07	5.25e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTEN—hypertension	4.66e-07	5.24e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK8—hypertension	4.66e-07	5.23e-06	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—hypertension	4.65e-07	5.23e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK8—hypertension	4.65e-07	5.22e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—hypertension	4.64e-07	5.22e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EGFR—hypertension	4.64e-07	5.21e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—hypertension	4.63e-07	5.21e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—hypertension	4.62e-07	5.18e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EP300—hypertension	4.61e-07	5.18e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOB—hypertension	4.61e-07	5.18e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—hypertension	4.58e-07	5.14e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MYC—hypertension	4.58e-07	5.14e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—hypertension	4.57e-07	5.13e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK8—hypertension	4.56e-07	5.12e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MYC—hypertension	4.56e-07	5.12e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—hypertension	4.55e-07	5.11e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—hypertension	4.55e-07	5.1e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EP300—hypertension	4.54e-07	5.1e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EP300—hypertension	4.53e-07	5.09e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—EP300—hypertension	4.53e-07	5.08e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—hypertension	4.52e-07	5.08e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GSTM1—hypertension	4.49e-07	5.04e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SRC—hypertension	4.49e-07	5.04e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EGFR—hypertension	4.48e-07	5.03e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EGFR—hypertension	4.46e-07	5e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—hypertension	4.45e-07	4.99e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EP300—hypertension	4.45e-07	4.99e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MYC—hypertension	4.43e-07	4.98e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—hypertension	4.42e-07	4.97e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—hypertension	4.42e-07	4.96e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SRC—hypertension	4.42e-07	4.96e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LPL—hypertension	4.41e-07	4.95e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SRC—hypertension	4.41e-07	4.95e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—hypertension	4.37e-07	4.91e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—hypertension	4.37e-07	4.91e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MYC—hypertension	4.36e-07	4.9e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—hypertension	4.36e-07	4.89e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—hypertension	4.35e-07	4.89e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CDKN1A—hypertension	4.34e-07	4.88e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EGFR—hypertension	4.33e-07	4.87e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTEN—hypertension	4.33e-07	4.86e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SRC—hypertension	4.32e-07	4.86e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—hypertension	4.32e-07	4.85e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ADCY5—hypertension	4.31e-07	4.84e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—hypertension	4.3e-07	4.83e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GPX1—hypertension	4.3e-07	4.83e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—hypertension	4.29e-07	4.82e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EGFR—hypertension	4.27e-07	4.79e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—hypertension	4.26e-07	4.78e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PRKCA—hypertension	4.26e-07	4.78e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP1A1—hypertension	4.26e-07	4.78e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK8—hypertension	4.24e-07	4.76e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—hypertension	4.23e-07	4.75e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3R1—hypertension	4.23e-07	4.75e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—hypertension	4.23e-07	4.75e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—hypertension	4.21e-07	4.73e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CD36—hypertension	4.19e-07	4.7e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—hypertension	4.17e-07	4.68e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EP300—hypertension	4.13e-07	4.64e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—hypertension	4.1e-07	4.61e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MYC—hypertension	4.02e-07	4.52e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SRC—hypertension	4.02e-07	4.51e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—hypertension	4.01e-07	4.5e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—hypertension	4e-07	4.5e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—hypertension	3.97e-07	4.46e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MYC—hypertension	3.96e-07	4.44e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—hypertension	3.95e-07	4.44e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MYC—hypertension	3.95e-07	4.43e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—hypertension	3.95e-07	4.43e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—hypertension	3.94e-07	4.42e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EGFR—hypertension	3.93e-07	4.42e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.91e-07	4.39e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—hypertension	3.9e-07	4.38e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARA—hypertension	3.89e-07	4.37e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MYC—hypertension	3.87e-07	4.35e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—hypertension	3.87e-07	4.35e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EGFR—hypertension	3.87e-07	4.35e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—hypertension	3.86e-07	4.34e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EGFR—hypertension	3.86e-07	4.34e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EGFR—hypertension	3.79e-07	4.26e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AGT—hypertension	3.77e-07	4.23e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—hypertension	3.76e-07	4.22e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—hypertension	3.74e-07	4.2e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CALM1—hypertension	3.71e-07	4.16e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—hypertension	3.69e-07	4.15e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOE—hypertension	3.69e-07	4.15e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—hypertension	3.68e-07	4.13e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAV1—hypertension	3.66e-07	4.11e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOA1—hypertension	3.65e-07	4.1e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—hypertension	3.64e-07	4.09e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—hypertension	3.64e-07	4.09e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MYC—hypertension	3.6e-07	4.04e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.59e-07	4.03e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—hypertension	3.58e-07	4.02e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—hypertension	3.57e-07	4.01e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EGFR—hypertension	3.52e-07	3.95e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—hypertension	3.44e-07	3.87e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—hypertension	3.43e-07	3.85e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTEN—hypertension	3.38e-07	3.79e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—hypertension	3.33e-07	3.74e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—hypertension	3.3e-07	3.71e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—hypertension	3.29e-07	3.69e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—hypertension	3.28e-07	3.68e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—hypertension	3.25e-07	3.65e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—hypertension	3.24e-07	3.64e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—EP300—hypertension	3.22e-07	3.62e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—hypertension	3.22e-07	3.61e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—hypertension	3.18e-07	3.57e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—hypertension	3.18e-07	3.57e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—hypertension	3.17e-07	3.56e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—hypertension	3.16e-07	3.55e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—INS—hypertension	3.16e-07	3.54e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—hypertension	3.07e-07	3.45e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—hypertension	3.02e-07	3.4e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—hypertension	3.02e-07	3.39e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—hypertension	2.99e-07	3.35e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—hypertension	2.97e-07	3.34e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—hypertension	2.97e-07	3.33e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—hypertension	2.96e-07	3.32e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—hypertension	2.91e-07	3.27e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—hypertension	2.89e-07	3.25e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—hypertension	2.79e-07	3.13e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—hypertension	2.77e-07	3.11e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3R1—hypertension	2.77e-07	3.11e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—hypertension	2.74e-07	3.08e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—hypertension	2.74e-07	3.07e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—hypertension	2.74e-07	3.07e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—hypertension	2.71e-07	3.04e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—hypertension	2.69e-07	3.02e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—hypertension	2.53e-07	2.84e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—hypertension	2.5e-07	2.8e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTEN—hypertension	2.21e-07	2.48e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—EP300—hypertension	2.1e-07	2.36e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—hypertension	1.95e-07	2.18e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—hypertension	1.27e-07	1.43e-06	CbGpPWpGaD
